FDA NDC Directory · JSON-LD · Markdown

Natesto nasal gel

NDC 42667-5511 · HUMAN PRESCRIPTION DRUG · GEL, METERED

Generic nametestosterone
Labeler / ManufacturerAcerus Pharmaceuticals Corporation
Marketing categoryNew Drug Application (innovator) · App NDA205488
Dosage form / routeGEL, METERED · NASAL
Active ingredientsTESTOSTERONE (5.5 mg/.122g)
Marketing started20200508
Package count1

External sources

Source: openFDA. Public-domain (CC0).